IMM

IMMUTEP LTD

• The Motley Fool·1d ago

  Up 43% since December, ASX 300 healthcare share announces milestone achievement

• ASX·1d ago

  Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC

• ASX·2d ago

  Change in substantial holding

• The Motley Fool·01/29 03:39

  This ASX biotech just smashed its quarterly update. So why are its shares falling?

• ASX·01/29 00:37

  Immutep Quarterly Activities Report and Appendix 4C

• ASX·12/30/2025 21:30

  Change in substantial holding

• The Motley Fool·12/21/2025 23:55

  Clinical trial of potential diabetes and arthritis treatment delivers positive results

• ASX·12/21/2025 21:28

  Positive Update on IMP761 Phase 1

• ASX·12/15/2025 21:37

  TACTI-004 phase III trial enrolment continues at robust pace

• The Motley Fool·12/09/2025 23:15

  Broker says this small cap ASX stock can rise ~90% following 'impressive deal'

• Dow Jones·12/09/2025 21:30

  *Immutep Target Price Raised 30% to A$0.60/Share by Bell Potter>IMM.AU

• Dow Jones·12/09/2025 21:26

  *Immutep Target Price Raised 4.8% to A$2.20/Share by Jefferies>IMM.AU

• The Motley Fool·12/09/2025 02:10

  Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

• The Motley Fool·12/08/2025 23:53

  Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

• ASX·12/08/2025 07:25

  Immutep enters into Strategic Collaboration with Dr. Reddy's